Beyond whole chromosome counts, specific variations in the CFHR3 and TNFRSF4 genes are linked to the disruption of immune tolerance required to maintain a healthy pregnancy. For approximately one percent of couples worldwide, the journey toward parenthood is interrupted by recurrent pregnancy loss,
The approval of Guardant360 CDx as a companion diagnostic for AstraZeneca’s camizestrant marks the first time a liquid biopsy has been authorized for continuous monitoring of cancer evolution. This regulatory milestone fundamentally alters the management of advanced breast cancer by allowing
While immunotherapy was previously confined to treating advanced stages of the disease, new evidence shows its efficacy in earlier, resectable settings. Gastric cancer has long remained a formidable opponent within the global oncology landscape, currently ranking as the fifth most common cancer
The inherent inefficiencies of the autologous model are tied to a one-batch-per-patient approach that restricts throughput and maintains high market prices for oncology treatments. While Chimeric Antigen Receptor (CAR) T-cell therapies have redefined oncology by providing life-saving results for
While medication abortion is FDA-approved for use up to eleven weeks of pregnancy, a new legal effort argues that state-level bans are being undermined by mail-order access. This challenge, currently centered in Louisiana, targets the regulatory framework that allows physicians to prescribe
Although lamotrigine is a staple treatment for bipolar disorder and epilepsy, it triggers a dangerous systemic immune response in approximately one out of every thousand patients. Known as Stevens-Johnson Syndrome, this reaction causes severe skin detachment and organ damage. For years, doctors
